Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04690205 · ClinicalTrials.gov registry record · NA
Hospital at Home at EOL in Heme Malignancies
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT04690205: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04690205 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04690205, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
This study is evaluating an intervention, which the investigators call "Optimize End of Life (EOL) Care at Home," that entails remote patient monitoring and home-based supportive care for patients with advanced hematologic malignancies.
Interventions
- OTHER End of Life (EOL) Care at at Home
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2021-02-26 |
| Est. Completion | 2025-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04690205
The ClinicalTrials.gov registry entry for NCT04690205 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which End of Life (EOL) Care at at Home is the first listed.
NCT04690205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04690205 about?
NCT04690205 is a clinical study titled "Hospital at Home at EOL in Heme Malignancies". This study is evaluating an intervention, which the investigators call "Optimize End of Life (EOL) Care at Home," that entails remote patient monitoring and home-based supportive care for patients with advanced hematologic malignancies.
What is the current status of trial NCT04690205?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2021-02-26. Estimated completion is 2025-07-01.
What interventions are being tested in trial NCT04690205?
The interventions under investigation include: End of Life (EOL) Care at at Home (OTHER).
Who is sponsoring clinical trial NCT04690205?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.